{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-001642","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2025-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.498650+00:00","generated_at":"2026-05-17T07:57:45.096480+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Artelo Biosciences closes $3M public offering of common stock and pre-funded warrants","bullets":["Closed underwritten offering of 640,924 shares at $4.40/share and 40,894 pre-funded warrants at $4.399 each.","Gross proceeds of ~$3.0 million; underwriter has 45-day option for an additional 102,272 shares.","Net proceeds to advance preclinical/clinical development of product candidates and for working capital.","R.F. Lafferty & Co. acted as sole book-running manager; offering closed on September 5, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-001642","json":"https://secwatch.observer/filing/0001640334-25-001642.json","markdown":"https://secwatch.observer/filing/0001640334-25-001642.md","text":"https://secwatch.observer/filing/0001640334-25-001642.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001642/0001640334-25-001642-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001642/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:57:45.096480+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}